Join
Live feed
·
PRReleasevia Quantisnow
CDT Equity Inc. logo

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

ByQuantisnow·Wall Street's wire, on your screen.
CDT· CDT Equity Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDT (CDT Equity Inc.) and more on Quantisnow.